Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study.

Buus R, Sestak I, Barron S, Loughman T, Fender B, Ruiz CL, Dynoodt P, Wang CA, O'Leary D, Gallagher WM, Dowsett M, Cuzick J.

Clin Cancer Res. 2020 Feb 1;26(3):623-631. doi: 10.1158/1078-0432.CCR-19-0712. Epub 2019 Oct 22.

2.

Validation of a membrane touch biosensor for the qualitative detection of IgG class antibodies to herpes simplex virus type 2.

Loughman T, Singh B, Seddon B, Noone P, Santhosh P.

Analyst. 2017 Jul 24;142(15):2725-2734. doi: 10.1039/c7an00666g.

PMID:
28708188
3.

Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.

Forsblom C, Moran J, Harjutsalo V, Loughman T, Wadén J, Tolonen N, Thorn L, Saraheimo M, Gordin D, Groop PH, Thomas MC; FinnDiane Study Group.

Diabetes Care. 2014 Aug;37(8):2334-42. doi: 10.2337/dc14-0225. Epub 2014 May 30.

PMID:
24879837

Supplemental Content

Loading ...
Support Center